BR-01T

N/A

Report date: 2023/10/19 14:00:09

Base Information

Drug NameBR-01T
Drug Alias NameBR01TBR-01T
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNerve growth factor receptor Trk-A inhibitors
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXiyuan Anjian Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiyuan Anjian Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A